Image

Neurostimulation for Sleep Disordered Breathing

Neurostimulation for Sleep Disordered Breathing

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This is a first in human study to determine if the Lunair Alpha System is safe and effective for treating moderate to severe sleep disordered breathing.

Eligibility

Inclusion Criteria:

  • Subject does not tolerate, not compliant to or have access to alternative Sleep Disordered Breathing treatments
  • Subject has moderate to severe sleep disordered breathing as diagnosed by PSG

Exclusion Criteria:

  • Subject is taking opioids, narcotics, sleep or psychotic medications or supplements that may alter consciousness, the pattern of respiration, sleep architecture, or with known effect on sleep-wake function or alertness.
  • Any reason for which, in the judgment of the investigator, the subject is considered to be a poor study candidate
  • Subject has previous upper respiratory tract (URT) surgery or procedure (e.g., uvula, soft palate or tonsils) within 60 days prior to Screening PSG.
  • Subject has a need for chronic supplemental oxygen therapy for any reason
  • Subject has other sleep disorders or sleep hygiene behaviors that confound functional assessments of sleepiness
  • Subject has severe chronic kidney disease
  • Subject exhibits ongoing misuse of alcohol, tobacco, caffeine, or recreational drugs that would impact either the results of or the participation in a sleep study.
  • Subject conducts work or regular activities requiring vigilance
  • Subject is unwilling or unable to refrain from consumption of alcoholic beverages for 24 hours prior to the start of each PSG study.
  • Subject is unwilling or unable to refrain from sleep disordered breathing treatments or devices
  • Subject has an active systemic infection at time of implant.
  • Subject has clinical evidence of immunodeficiency.
  • Any condition likely to require future MRI or diathermy
  • Subject is pregnant
  • Subject has a severe nasal obstruction that could restrict airflow
  • Subject has any trauma to the upper airway
  • Subject has previous surgical resection, prior or current radiation therapy for cancer or congenital malformations in the larynx, tongue, or throat.

Study details
    Sleep Disordered Breathing (SDB)
    Sleep Apnea

NCT06883617

Lunair Medical

29 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.